495 related articles for article (PubMed ID: 20497701)
41. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
42. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753
[TBL] [Abstract][Full Text] [Related]
43. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
44. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
45. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
[TBL] [Abstract][Full Text] [Related]
46. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
[TBL] [Abstract][Full Text] [Related]
47. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
48. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
49. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
[TBL] [Abstract][Full Text] [Related]
50. Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy.
Abu El-Asrar AM; Nawaz MI; Kangave D; Siddiquei MM; Ola MS; Opdenakker G
Acta Diabetol; 2013 Aug; 50(4):545-51. PubMed ID: 21947384
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
52. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
53. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
Yan Y; Zhu L; Hong L; Deng J; Song Y; Chen X
Acta Ophthalmol; 2016 Jun; 94(4):358-64. PubMed ID: 26285163
[TBL] [Abstract][Full Text] [Related]
54. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
[TBL] [Abstract][Full Text] [Related]
55. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.
Hirata C; Nakano K; Nakamura N; Kitagawa Y; Shigeta H; Hasegawa G; Ogata M; Ikeda T; Sawa H; Nakamura K; Ienaga K; Obayashi H; Kondo M
Biochem Biophys Res Commun; 1997 Jul; 236(3):712-5. PubMed ID: 9245719
[TBL] [Abstract][Full Text] [Related]
56. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Hori S
Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846
[TBL] [Abstract][Full Text] [Related]
57. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
58. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
Yokoi M; Yamagishi S; Saito A; Yoshida Y; Matsui T; Saito W; Hirose S; Ohgami K; Kase M; Ohno S
Br J Ophthalmol; 2007 Jul; 91(7):885-7. PubMed ID: 17301120
[TBL] [Abstract][Full Text] [Related]
59. Novel role of erythropoietin in proliferative diabetic retinopathy.
Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
[TBL] [Abstract][Full Text] [Related]
60. [Role of chemokines in the vitreous of proliferative diabetic retinopathy].
Kawashima M; Shoji J; Kamura Y; Sato Y
Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):596-602. PubMed ID: 16218438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
